Alexandria Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $263K | Hold |
1,849
| – | – | 0.02% | 228 |
|
|
2021
Q2 | $289K | Hold |
1,849
| – | – | 0.03% | 227 |
|
|
2021
Q1 | $287K | Sell |
1,849
-41
| -2% | -$6.35K | 0.03% | 227 |
|
|
2020
Q4 | $283K | Hold |
1,890
| – | – | 0.03% | 219 |
|
|
2020
Q3 | $250K | Sell |
1,890
-52
| -3% | -$6.79K | 0.03% | 221 |
|
|
2020
Q2 | $225K | Buy |
+1,942
| New | +$224K | 0.03% | 222 |
|
|
2020
Q1 | – | Sell |
-1,993
| Closed | -$290K | – | 261 |
|
|
2019
Q4 | $290K | Sell |
1,993
-24
| -1% | -$3.31K | 0.04% | 215 |
|
|
2019
Q3 | $269K | Hold |
2,017
| – | – | 0.04% | 207 |
|
|
2019
Q2 | $231K | Hold |
2,017
| – | – | 0.03% | 242 |
|
|
2019
Q1 | $250K | Hold |
2,017
| – | – | 0.04% | 232 |
|
|
2018
Q4 | $203K | Buy |
2,017
+41
| +2% | +$4.61K | 0.03% | 243 |
|
|
2018
Q3 | $252K | Hold |
1,976
| – | – | 0.04% | 211 |
|
|
2018
Q2 | $213K | Hold |
1,976
| – | – | 0.03% | 221 |
|
|
2018
Q1 | $209K | Hold |
1,976
| – | – | 0.03% | 223 |
|
|
2017
Q4 | $232K | Buy |
1,976
+1,741
| +741% | +$197K | 0.03% | 220 |
|
|
2017
Q3 | $27K | Hold |
235
| – | – | 0.01% | 319 |
|
|
2017
Q2 | $29K | Sell |
235
-86
| -27% | -$10.2K | 0.01% | 307 |
|
|
2017
Q1 | $38K | Hold |
321
| – | – | 0.01% | 270 |
|
|
2016
Q4 | $32K | Buy |
321
+1
| +0.3% | +$107 | 0.01% | 300 |
|
|
2016
Q3 | $40K | Buy |
320
+1
| +0.3% | +$124 | 0.01% | 267 |
|
|
2016
Q2 | $37K | Hold |
319
| – | – | 0.01% | 282 |
|
|
2016
Q1 | $33K | Buy |
319
+1
| +0.3% | +$97 | 0.01% | 291 |
|
|
2015
Q4 | $32K | Buy |
318
+1
| +0.3% | +$98 | 0.01% | 313 |
|
|
2015
Q3 | $29K | Hold |
317
| – | – | 0.01% | 282 |
|
|
2015
Q2 | $34K | Buy |
317
+1
| +0.3% | +$111 | 0.01% | 276 |
|
|
2015
Q1 | $36K | Hold |
316
| – | – | 0.01% | 239 |
|
|
2014
Q4 | $35K | Buy |
316
+1
| +0.3% | +$105 | 0.01% | 231 |
|
|
2014
Q3 | $31K | Buy |
315
+1
| +0.3% | +$98 | 0.01% | 250 |
|
|
2014
Q2 | $32K | Sell |
314
-98
| -24% | -$9.56K | 0.01% | 254 |
|
|
2014
Q1 | $38K | Sell |
412
-316
| -43% | -$29.1K | 0.02% | 235 |
|
|
2013
Q4 | $66K | Sell |
728
-381
| -34% | -$33K | 0.03% | 156 |
|
|
2013
Q3 | $88K | Sell |
1,109
-462
| -29% | -$36.4K | 0.04% | 146 |
|
|
2013
Q2 | $114K | Buy |
+1,571
| New | +$117K | 0.06% | 135 |
|
Other funds holding ZBH
Alexandria Capital's ZBH Position: Q3 2021 in Review
Alexandria Capital held its Zimmer Biomet (ZBH) position steady in Q3 2021 at 1,849 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #228.
Alexandria Capital first reported a position in ZBH in Q2 2013 and has held it in 33 quarters since. The position peaked at $290K in Q4 2019. 983 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.
- Alexandria Capital held 1,849 shares of Zimmer Biomet worth $263K as of Q3 2021.
- Alexandria Capital left its Zimmer Biomet share count unchanged in Q3 2021.
- Zimmer Biomet made up 0.02% of Alexandria Capital's portfolio in Q3 2021, its #228 holding.
- Alexandria Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 33 quarters since.
- Alexandria Capital's Zimmer Biomet position peaked at $290K in Q4 2019.
- 983 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.